Effects of Carnosine Supplementation on Cognitive Outcomes in Prediabetes and Well-Controlled Type 2 Diabetes: A Randomised Placebo-Controlled Clinical Trial

<b>Background:</b> Trends in global ageing underscore the rising burden of age-related cognitive decline and concomitant cardiometabolic diseases, including type 2 diabetes mellitus (T2DM). Carnosine, a naturally occurring dipeptide with anti-inflammatory, antioxidant and anti-glycating...

Full description

Bibliographic Details

Published in:	Pharmaceuticals
Main Authors:	Rohit Hariharan, Aya Mousa, Kirthi Menon, Jack Feehan, Barbara Ukropcová, Jozef Ukropec, Martin Schön, Arshad Majid, Giancarlo Aldini, Maximilian de Courten, James Cameron, Simon M. Bell, Barbora de Courten
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Subjects:	carnosine supplementation cognition and diabetes cognitive function prediabetes and cognition type 2 diabetes neurocognitive outcomes
Online Access:	https://www.mdpi.com/1424-8247/18/5/630